CIK 0001615219 · Non-accelerated filer<br>Smaller reporting company
Decoy Therapeutics Inc.
Sign in to watch- Ticker
- DCOY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465087339
- Phone
- 346-772-0346
- Business address
- 2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
- 4 Open-market buy Director bought 37,500 shares at $0.19 ($7,016)
- 4 Open-market buy Director bought 26,553 shares at $0.19 ($5,000)
- 4 Open-market buy Director bought 28,000 shares at $0.18 ($5,152)
- 4/A Open-market buy Director bought 4,000 shares at $0.98 ($3,920)
- 4/A Open-market buy Director bought 4,350 shares at $1.15 ($5,003)
- 4/A Open-market buy Director bought 3,000 shares at $3.59 ($10,770)
- 4 Open-market buy Chief Executive Officer bought 43,900 shares at an average $0.18 ($7,985)
- 4 Open-market buy Exec VP Finance, CFO bought 28,000 shares at $0.18 ($5,040)
- DEFA14A Proxy Proxy Materials
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- D Other Notice of Sales of Unregistered Securities
- 4 Grant or award Chief Executive Officer acquired 10,000 shares (grant or award)
- 4 Grant or award Exec VP Finance, CFO acquired 10,000 shares (grant or award)
- SC 13G Stake Amended Statement of Ownership
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SC 13G Stake Amended Statement of Ownership
Page 12 of 38 · 744 filings